Global Antivenom Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Antivenom Drugs market size was valued at US$ 1201 million in 2024 and is forecast to a readjusted size of USD 1506 million by 2031 with a CAGR of 3.3% during review period.

Antivenom drugs are used to treat venomous bites and stings, usually preferable in high-toxicity cases. Antivenin, venom antiserum, and antivenom immunoglobulin are the different other names of antivenom drugs. These medications can potentially reverse the effects of snake bites, and generally, an adequate therapeutic dose is injected. Additionally, these medications also help in kidney dialysis, artificial respiration, prosthesis as well as rehabilitation services.

There are more than 3,000 species of snakes in the world, of which about 250 are prioritized by the WHO because of the potential for serious injury from their venom, spread across 160 countries around the world, the WHO said. Snakebites mainly occur in developing countries in tropical and subtropical regions. Sub-Saharan Africa, tropical Asia, New Guinea, and central and southern America are all high incidence areas of snakebite. In India alone, as many as 2.8 million people are bitten by snakes every year, and more than 46,000 of them die. Rising number of people bitten by snakes is the key driver for the growth of the antivenom market.

This report is a detailed and comprehensive analysis for global Antivenom Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Antivenom Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antivenom Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antivenom Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antivenom Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antivenom Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antivenom Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioclone Institute, Pfizer Inc, Merck KGaA, VINS Bioproducts Ltd, BTG International Inc, Incepta Pharma, Bharat Serums and Vaccines Limited, Boston Scientific Corporation, Alomone Labs, Wyeth, LLC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Antivenom Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Monovalent

Polyvalent

Market segment by Application

Hospital

Clinical Laboratory

Field Rescue Station

Other

Major players covered

Bioclone Institute

Pfizer Inc

Merck KGaA

VINS Bioproducts Ltd

BTG International Inc

Incepta Pharma

Bharat Serums and Vaccines Limited

Boston Scientific Corporation

Alomone Labs

Wyeth, LLC

Serum Biotech

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Antivenom Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Antivenom Drugs, with price, sales quantity, revenue, and global market share of Antivenom Drugs from 2020 to 2025.

Chapter 3, the Antivenom Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Antivenom Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antivenom Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Antivenom Drugs.

Chapter 14 and 15, to describe Antivenom Drugs sales channel, distributors, customers, research findings and conclusion.